secwatch.observer — SEC 8-K summary
======================================

Issuer:     Advanced Biomed Inc. (ADVB)
CIK:        0001941029
Form:       8-K
Filed at:   2025-07-24T23:59:59+00:00
Accession:  0001213900-25-067328
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Advanced Biomed receives Nasdaq bid price deficiency notice; has 180 days to regain compliance
--------------------------------------------------------------------------------

- Nasdaq notified ADVB on July 18, 2025, of bid price below $1.00 for 32 consecutive business days.
- Company has until Jan 14, 2026 to regain compliance; must close at $1.00+ for 10 consecutive days.
- If not cured, ADVB may get an extra 180 days if it meets other Nasdaq initial listing standards.
- Company may consider a reverse stock split or other options to remedy the deficiency.
- Common stock continues trading under symbol ADVB on Nasdaq Capital Market with no immediate impact.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1941029/000121390025067328/0001213900-25-067328-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1941029/000121390025067328/ea025015701-8k_advanced.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-067328

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer